165 related articles for article (PubMed ID: 12488316)
1. Pathways accessory to proteasomal proteolysis are less efficient in major histocompatibility complex class I antigen production.
Kessler B; Hong X; Petrovic J; Borodovsky A; Dantuma NP; Bogyo M; Overkleeft HS; Ploegh H; Glas R
J Biol Chem; 2003 Mar; 278(12):10013-21. PubMed ID: 12488316
[TBL] [Abstract][Full Text] [Related]
2. MHC class I antigen processing regulated by cytosolic proteolysis-short cuts that alter peptide generation.
Kessler BM; Glas R; Ploegh HL
Mol Immunol; 2002 Oct; 39(3-4):171-9. PubMed ID: 12200049
[TBL] [Abstract][Full Text] [Related]
3. The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides.
Goldberg AL; Cascio P; Saric T; Rock KL
Mol Immunol; 2002 Oct; 39(3-4):147-64. PubMed ID: 12200047
[TBL] [Abstract][Full Text] [Related]
4. The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design.
Sijts A; Zaiss D; Kloetzel PM
Curr Mol Med; 2001 Dec; 1(6):665-76. PubMed ID: 11899255
[TBL] [Abstract][Full Text] [Related]
5. Multiple proteases process viral antigens for presentation by MHC class I molecules to CD8(+) T lymphocytes.
Del-Val M; López D
Mol Immunol; 2002 Oct; 39(3-4):235-47. PubMed ID: 12200053
[TBL] [Abstract][Full Text] [Related]
6. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
[TBL] [Abstract][Full Text] [Related]
7. A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway.
Herberts CA; Stittelaar KJ; van der Heeft E; van Gaans-van den Brink J; Poelen MCM; Roholl PJM; van Alphen LJW; Melief CJM; de Jong APJM; van Els CACM
J Gen Virol; 2001 Sep; 82(Pt 9):2131-2142. PubMed ID: 11514722
[TBL] [Abstract][Full Text] [Related]
8. Protein degradation and the generation of MHC class I-presented peptides.
Rock KL; York IA; Saric T; Goldberg AL
Adv Immunol; 2002; 80():1-70. PubMed ID: 12078479
[TBL] [Abstract][Full Text] [Related]
9. Beyond the proteasome: trimming, degradation and generation of MHC class I ligands by auxiliary proteases.
Saveanu L; Fruci D; van Endert P
Mol Immunol; 2002 Oct; 39(3-4):203-15. PubMed ID: 12200051
[TBL] [Abstract][Full Text] [Related]
10. Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis.
Mukherjee P; Dani A; Bhatia S; Singh N; Rudensky AY; George A; Bal V; Mayor S; Rath S
J Immunol; 2001 Sep; 167(5):2632-41. PubMed ID: 11509605
[TBL] [Abstract][Full Text] [Related]
11. Post-proteasomal antigen processing for major histocompatibility complex class I presentation.
Rock KL; York IA; Goldberg AL
Nat Immunol; 2004 Jul; 5(7):670-7. PubMed ID: 15224092
[TBL] [Abstract][Full Text] [Related]
12. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway.
Harding CV; France J; Song R; Farah JM; Chatterjee S; Iqbal M; Siman R
J Immunol; 1995 Aug; 155(4):1767-75. PubMed ID: 7636233
[TBL] [Abstract][Full Text] [Related]
13. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
Bai A; Forman J
J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
[TBL] [Abstract][Full Text] [Related]
14. Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system.
Niedermann G; Grimm R; Geier E; Maurer M; Realini C; Gartmann C; Soll J; Omura S; Rechsteiner MC; Baumeister W; Eichmann K
J Exp Med; 1997 Jul; 186(2):209-20. PubMed ID: 9221750
[TBL] [Abstract][Full Text] [Related]
15. Proteasome and class I antigen processing and presentation.
Belich MP; Trowsdale J
Mol Biol Rep; 1995; 21(1):53-6. PubMed ID: 7565665
[TBL] [Abstract][Full Text] [Related]
16. A proteolytic system that compensates for loss of proteasome function.
Glas R; Bogyo M; McMaster JS; Gaczynska M; Ploegh HL
Nature; 1998 Apr; 392(6676):618-22. PubMed ID: 9560160
[TBL] [Abstract][Full Text] [Related]
17. To DRiP or not to DRiP: generating peptide ligands for MHC class I molecules from biosynthesized proteins.
Yewdell J
Mol Immunol; 2002 Oct; 39(3-4):139-46. PubMed ID: 12200046
[No Abstract] [Full Text] [Related]
18. Phosphatidylserine receptor-mediated recognition of archaeosome adjuvant promotes endocytosis and MHC class I cross-presentation of the entrapped antigen by phagosome-to-cytosol transport and classical processing.
Gurnani K; Kennedy J; Sad S; Sprott GD; Krishnan L
J Immunol; 2004 Jul; 173(1):566-78. PubMed ID: 15210818
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides.
Antón LC; Snyder HL; Bennink JR; Vinitsky A; Orlowski M; Porgador A; Yewdell JW
J Immunol; 1998 May; 160(10):4859-68. PubMed ID: 9590233
[TBL] [Abstract][Full Text] [Related]
20. A role for the proteasome regulator PA28alpha in antigen presentation.
Groettrup M; Soza A; Eggers M; Kuehn L; Dick TP; Schild H; Rammensee HG; Koszinowski UH; Kloetzel PM
Nature; 1996 May; 381(6578):166-8. PubMed ID: 8610016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
